ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Peeteepoo
|
59 |
14K |
4 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
59
|
14K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
5 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
227
|
53K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Peeteepoo
|
59 |
14K |
12 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
59
|
14K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
4 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
227
|
53K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
8 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
227
|
53K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
5 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
227
|
53K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
27 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
227
|
53K
|
27
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
10 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
227
|
53K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
10 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
227
|
53K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
8 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
227
|
53K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
10 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
227
|
53K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
4 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
227
|
53K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
21 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
227
|
53K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
18 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
227
|
53K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
31 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
227
|
53K
|
31
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
5 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
227
|
53K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
24 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
227
|
53K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Peeteepoo
|
227 |
53K |
25 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
227
|
53K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
Peeteepoo
|
104 |
18K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
104
|
18K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
Peeteepoo
|
104 |
18K |
12 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
104
|
18K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
332K |
20 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
1.3K
|
332K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
332K |
8 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.3K
|
332K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
332K |
5 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.3K
|
332K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
332K |
6 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.3K
|
332K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Dr Rebecca McQualter appointed COO
|
|
Peeteepoo
|
14 |
4.4K |
6 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
14
|
4.4K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
332K |
10 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.3K
|
332K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
332K |
15 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.3K
|
332K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
332K |
7 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
1.3K
|
332K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
PAA TOP HOLDERS MOVEMENTS AS AT 30 APRIL 2024
|
|
Peeteepoo
|
5 |
1.5K |
7 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
5
|
1.5K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
PAA TOP HOLDERS MOVEMENTS AS AT 30 APRIL 2024
|
|
Peeteepoo
|
5 |
1.5K |
4 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
5
|
1.5K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
332K |
5 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
1.3K
|
332K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
332K |
7 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
1.3K
|
332K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
332K |
9 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
332K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
332K |
10 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
332K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
332K |
9 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
332K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
332K |
15 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
332K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
332K |
12 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
332K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
Peeteepoo
|
104 |
18K |
9 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
104
|
18K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
66K |
16 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
261
|
66K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
66K |
11 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
261
|
66K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
66K |
8 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
261
|
66K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
66K |
25 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
261
|
66K
|
25
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Peeteepoo
|
1.3K |
332K |
9 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
1.3K
|
332K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
66K |
35 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
261
|
66K
|
35
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
66K |
25 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
261
|
66K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
66K |
6 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
66K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
Peeteepoo
|
32 |
9.3K |
16 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
32
|
9.3K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
66K |
20 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
66K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
66K |
6 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
66K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Peeteepoo
|
261 |
66K |
9 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
66K
|
9
|
|